Feb 19 (Reuters) - BBS-Bioactive Bone Substitutes Oyj
BONEH.HE :
* CLINICAL RESULT OF ARTEBONE IS POSITIVE YIELDING AN
OUTCOME
SIMILAR TO PATIENT'S OWN BONE GRAFT
* MAIN RESULT SHOWS THAT FUSION RATE WITH ARTEBONE PASTE IS
COMPARABLE WITH FUSION RATE WITH AUTOGRAFT
* NO SYNTHETIC SUBSTITUTE MATERIAL HAS SHOWN SIMILAR BONE
GROWTH
POTENTIAL WHILE KEEPING SAFETY AT HIGH LEVEL
* RESULTS WERE COMPARED TO LITERATURE REFERENCES ON
AUTOGRAFT
* EXPECTS TO RECEIVE CE MARKING OF ARTEBONE, TO BE ABLE TO
START
COMMERCIAL OPERATIONS IN EUROPEAN MARKETS WITHIN A YEAR
* CO IS AIMING TO START BUILDING ITS MARKETING AND SALES
NETWORK
STARTING IN LATE SPRING
Source text for Eikon: ID:nGNEbPC30Y
Further company coverage: BONEH.HE
((Reuters.Briefs@thomsonreuters.com;))